Search results
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 2 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Journal of Free Speech Law: "FDA Regulation of Physicians’ Professional Speech," by Prof. Barbara J....
Reason.com· 1 day agoOn September 28, 2022, after six years of effort and two draft guidance documents, the U.S. Food and Drug Administration (FDA) finalized its Guidance on Clinical Decision ...
New Alzheimer's drug brings hope to those dealing with the disease
NewsWest 9· 3 days agoOnce news of the FDA Advisory Council’s recent unanimous endorsement of the drug donanemab reached...
Some hawking stem cells say they can treat almost anything. They can't
Billings Gazette· 7 hours agoAttorneys general across the U.S. have a new fight on their hands: protecting Americans from...
Alzheimer's in Kern: a new drug is being tested that could bring hope.
KERO 23 Bakersfield· 23 hours agoThe FDA is currently in the process of approving a new drug, that will slow down the affects of Alzheimer's Disease by 18 months. In California alone over 700,000 people are ...
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy...
Morningstar· 7 hours agoAurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001 First allogeneic cell therapy to receive both & ...
Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead...
The Joplin Globe· 2 days ago"We are pleased with the outcome of our recently received feedback from the FDA and are excited to progress the development program for our novel buccal delivery asset, TH104 ...